Anti-MAdCAM Antibody Increases ß7+ T Cells and CCR9 Gene Expression in the Peripheral Blood of Patients With Crohn’s Disease
Mina Hassan‐Zahraee(Pfizer (United States)), Kenneth E. Hung(Pfizer (United States)), Padma Reddy(Pfizer (United States)), Mireia Fernández Ocaña(Pfizer (United States)), Fabio Cataldi(Pfizer (United States)), Alaa Ahmad(All India Institute of Medical Sciences), Satyaprakash Nayak(Pfizer (United States)), Ken Gorelick(Pfizer (United States)), Michael S. Vincent(Pfizer (United States)), David von Schack(Pfizer (United States)), Karen Page(Pfizer (United States)), Xi Li(Sichuan University), Weidong Zhang(Pfizer (United States)), Baohong Zhang(Pfizer (United States)), Anindita Banerjee(Pfizer (United States)), John B. Cheng(Pfizer (United States)), Hendrik Neubert(Pfizer (United States)), Steven W. Martin(Mississippi Delta Community College), Robert Clare(Pfizer (United States))
Cited by 26
Related Papers
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
|Nature Metabolism|2020|775
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies
|The Lancet|2023|350
Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226
|The Journal of Immunology|2015|264